Clinical Trial Update: Prospective Trial of Treat and Extend Aflibercept for Macular Edema Secondary to Branch Retinal Vein Occlusion [Phase 4]

View source ↗

Summary

A Phase 4 prospective trial evaluating a treat-and-extend approach with aflibercept for macular edema due to branch retinal vein occlusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Branch Retinal Vein Occlusion with Macular Edema

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: Yeungnam University College of Medicine | Conditions: Branch Retinal Vein Occlusion With Macular Edema | Phase 4 | Status: UNKNOWN